Glaukos Announces Participation in the William Blair Growth Stock Conference

Rhea-AI Summary

Glaukos Corporation (NYSE: GKOS) announced its participation in the William Blair 42nd Annual Growth Stock Conference scheduled for June 8, 2022, at 8:40 a.m. CT in Chicago, IL. The event will feature a live and archived webcast available on the company's investor relations website. Glaukos focuses on innovative ophthalmic medical technologies targeting glaucoma, corneal disorders, and retinal diseases, having pioneered Micro-Invasive Glaucoma Surgery (MIGS) with its first device launched in 2012. The company continues to advance treatment options in these areas through ongoing innovations.

Positive

• Participation in a prominent investor conference boosts visibility and engagement with investors.
• Continued focus on innovation in ophthalmic solutions, potentially increasing market share.

Negative

• None.

SAN CLEMENTE, Calfi.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the William Blair 42^nd Annual Growth Stock Conference on Wednesday, June 8, 2022, at 8:40 a.m. CT in Chicago, IL.

A live and archived webcast for this event will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.

About Glaukos

Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012, and has since developed a portfolio of technologically distinct and leverageable platforms to support ongoing pharmaceutical and medical device innovations. Products or product candidates for each of these platforms are designed to advance the standard of care through better treatment options across the areas of glaucoma, corneal disorders and retinal diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005159/en/

Chris Lewis

Vice President, Investor Relations & Corporate Affairs

(949) 481-0510

clewis@glaukos.com

Source: Glaukos Corporation

FAQ

When is Glaukos Corporation presenting at the William Blair 42nd Annual Growth Stock Conference?

Glaukos Corporation will present at the conference on June 8, 2022, at 8:40 a.m. CT.

Where is the William Blair 42nd Annual Growth Stock Conference taking place?

The conference is being held in Chicago, IL.

What is Glaukos Corporation known for?

Glaukos Corporation specializes in ophthalmic medical technologies and is known for developing Micro-Invasive Glaucoma Surgery (MIGS).

How can I access the webcast of Glaukos Corporation's conference presentation?

The webcast can be accessed in the Investors section of Glaukos' website.